126 related articles for article (PubMed ID: 24280140)
1. Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction.
Šímová J; Škvor J; Slovák D; Mazura I; Zvárová J
Folia Biol (Praha); 2013; 59(5):181-7. PubMed ID: 24280140
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction.
Ghaderian SM; Akbarzadeh Najar R; Tabatabaei Panah AS
Coron Artery Dis; 2010 Sep; 21(6):330-5. PubMed ID: 20616708
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.
Eckart RE; Uyehara CF; Shry EA; Furgerson JL; Krasuski RA
J Interv Cardiol; 2004 Feb; 17(1):27-31. PubMed ID: 15009768
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
Kuliczkowski W; Urbaniak J; Hallén J; Woźniak M; Poloński L; Mysiak A; Atar D; Zembala M; Serebruany V
Kardiol Pol; 2013; 71(5):453-63. PubMed ID: 23788085
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
Wang KF; Huang PH; Chiang CH; Hsu CY; Leu HB; Chen JW; Lin SJ
Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
Karapanagiotidis GT; Antonitsis P; Charokopos N; Foroulis CN; Anastasiadis K; Rouska E; Argiriadou H; Rammos K; Papakonstantinou C
J Cardiothorac Surg; 2009 Nov; 4():59. PubMed ID: 19886986
[TBL] [Abstract][Full Text] [Related]
7. Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases-INVITATION Trial.
Shirakawa T; Fujisue K; Nakamura S; Yamamoto N; Oshima S; Matsumura T; Tsunoda R; Hirai N; Koide S; Tayama S; Kikuta K; Hirose T; Maruyama H; Fujimoto K; Kajiwara I; Sakamoto T; Nakao K; Sakaino N; Nagayoshi Y; Hokamaki J; Shimomura H; Sakamoto K; Yamamoto E; Izumiya Y; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
J Atheroscler Thromb; 2022 Feb; 29(2):229-241. PubMed ID: 33408315
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between serum MMP-2 and MMP-9 in patients with acute myocardial infarction before and after PCI].
Dai F; Xiao GL; Pan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):716-8. PubMed ID: 19664397
[TBL] [Abstract][Full Text] [Related]
10. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
Squire IB; Evans J; Ng LL; Loftus IM; Thompson MM
J Card Fail; 2004 Aug; 10(4):328-33. PubMed ID: 15309700
[TBL] [Abstract][Full Text] [Related]
11. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
12. Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction.
Owolabi US; Amraotkar AR; Coulter AR; Singam NSV; Aladili BN; Singh A; Trainor PJ; Mitra R; DeFilippis AP
J Thromb Thrombolysis; 2020 Feb; 49(2):235-244. PubMed ID: 31808123
[TBL] [Abstract][Full Text] [Related]
13. Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion.
Tanindi A; Sahinarslan A; Elbeg S; Cemri M
Coron Artery Dis; 2011 Jun; 22(4):253-8. PubMed ID: 21317638
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinases-2 and -9 predict left ventricular remodeling after myocardial infarction.
Cogni AL; Farah E; Minicucci MF; Azevedo PS; Okoshi K; Matsubara BB; Zanati S; Haggeman R; Paiva SA; Zornoff LA
Arq Bras Cardiol; 2013 Apr; 100(4):315-21. PubMed ID: 23525272
[TBL] [Abstract][Full Text] [Related]
15. Alteplase treatment affects circulating matrix metalloproteinase concentrations in patients with ST segment elevation acute myocardial infarction.
Tziakas DN; Chalikias GK; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris A; Hatseras DI; Kaski JC
Thromb Res; 2006; 118(2):221-7. PubMed ID: 16126256
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction.
Ghaderian SM; Najar RA; Tabatabaei Panah AS; Rezaie G; Rezaei Farimani A; Beigi Harchegani A; Azargashb E
J Thromb Thrombolysis; 2010 Nov; 30(4):404-11. PubMed ID: 20221893
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection.
Sangiorgi G; Trimarchi S; Mauriello A; Righini P; Bossone E; Suzuki T; Rampoldi V; Eagle KA
J Cardiovasc Med (Hagerstown); 2006 May; 7(5):307-15. PubMed ID: 16645407
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients.
Diekmann U; Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C
J Mol Med (Berl); 2009 Oct; 87(10):965-70. PubMed ID: 19575173
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.
Kaden JJ; Dempfle CE; Sueselbeck T; Brueckmann M; Poerner TC; Haghi D; Haase KK; Borggrefe M
Cardiology; 2003; 99(3):140-4. PubMed ID: 12824721
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase -9 polymorphism and outcome after acute myocardial infarction.
El-Aziz TAA; Mohamed RH
Int J Cardiol; 2017 Jan; 227():524-528. PubMed ID: 27825726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
